Bacteria and strains | Features | References | |
---|---|---|---|
Escherichia coli | ATCC 8739 | References strains | |
ATCC 10536 | References strains | ||
AG100 Atet | AG 100 sur-expressing AcrAB pumps, contaning TETR gène acrF | [14] | |
AG100 | Wild-typeE. ColiK-12 | [15] | |
AG102 | AG100 Sur-exprissingAcrAB pumps. | [17] | |
MC4100 | Wild typeE. coli | ||
Enterobacter aerogenes | ATCC 13048 | References strains | |
EA27 | Clinical MDR isolate exhibiting energy-dependent norfloxacin and chloramphenicol efflux with KANR AMPR NALR STRR TETR | [18] | |
EA-3 | Clinical MDR isolate CHLR, NORR, OFXR, SPXR, MOXR, CFTR, ATMR, FEPR | [18] | |
EA 289 | KAN sensitive derivative d’EA27 | [18] | |
EA 294 | EA289 sur-expressing AcrA pumps Exhibiting KANR | [18] | |
EA 298 | EA289 TolC KANR | [18] | |
CM64 | CHLRresistant variant obtained from ATCC13048 over-expressing the AcrAB pump | [18] | |
Klebsiella pneumoniae | ATCC 11296 | References strains | |
K-2 | Clinical MDR isolate exhibiting energy-dependent norfloxacin and chloramphenicol efflux with KANR AMPR NALR STRR TETR | Laboratory collection of UNR-MD1, University of Marseille, France | |
K-24 | AcrAB-Tolc | ||
KP 55 | Clinical isolate MDR, TETR, AMPR, ATMR, CEFR | [17] | |
KP 63 | Clinical isolate du MDR, TETR, CHLRAMPR, ATMR | [17] | |
Pseudomonas aeruginosa | PA01 | References strains | |
PA124 | MDR Clinical isolate | [15] | |
Providencia stuartii | ATCC 29916 | References strains | |
NAE16 | MDR clinical isolate AcrAB-TolC | [15] |